BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for June 30, 2023

June 30, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Health, B. Braun, Imagion Biosystems, Microbot, Nanalysis Scientific, Navidea, Pavmed, Pocdoc, Prophase, Rockwell Medical, Siemens Healthineers.
Read More

In the clinic for June 30, 2023

June 30, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioheart, Castle Biosciences, Novigenix.
Read More

Appointments and advancements for June 30, 2023

June 30, 2023
New hires and promotions in the med-tech industry, including: Baxter International, Solera Health.
Read More

Regulatory actions for June 30, 2023

June 30, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ausper, Bristol Myers Squibb, Can-Fite, Celltrans, Endo, Genenta, Geron, Harbour Biomed, Ipsen, Italfarmaco, Paladin Labs, Recce.
Read More

Other news to note for June 30, 2023

June 30, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Baudax, Bayer, Beigene, Biogenysis, Chime, Cytoreason, Domain, Eli Lilly, Emergence, Endo, Enzolytics, Evotec, Heidelberg, Kintara, Leaderna, Leads, Lipigon, Lucy, Navidea, Pasithea, Poolbeg, Prophase, Sagaliam, Teraimmune, Virogentics.
Read More

In the clinic for June 30, 2023

June 30, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akebia, Aldeyra,  Alumis, Amytrx, Astrazeneca, Biontech, Bioxcel, Delsitech, Haemalogix, Intrabio, Jacobio, Junshi, Nanoviricides, Oncoc4, Plus, Renovorx, Urica.
Read More

Financings for June 30, 2023

June 30, 2023
Biopharmas raising money in public or private financings, including: Aeon, Biosenic, Black Diamond, Cytomx, Eleison, Intensity, Kiromics, Mira, Vitro.
Read More

Appointments and advancements for June 30, 2023

June 30, 2023
New hires and promotions in the biopharma industry, including: Cybin, Sumitomo, Zymeworks.
Read More

Regulatory actions for June 29, 2023

June 29, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Candela, Cresilon, Zap Surgical.
Read More

Other news to note for June 29, 2023

June 29, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amplitude Surgical, Avanos, Changzhou Zhongjin Medical Equipment, Dermtech, Elios, Enovis, Integra, Intelligent Bio Solutions, Novastep, Shanghai Sdoma Smart Technology.
Read More
Previous 1 2 … 765 766 767 768 769 770 771 772 773 … 1808 1809 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

    BioWorld Science
    Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing